A carregar...
Ten years of biosimilar recombinant human growth hormone in Europe
Recombinant human growth hormone (rhGH) has been in clinical use for more than 30 years. With the expiration of patent exclusivity for the first wave of rhGH products and other biopharmaceuticals, the opportunity emerged for the development of biosimilar medicines. A biosimilar is defined by the Eur...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5439961/ https://ncbi.nlm.nih.gov/pubmed/28553081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S130317 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|